Henoch-Schonlein Purpura
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Henoch-Schonlein Purpura

What is the definition of Henoch-Schonlein Purpura?
Henoch-Schonlein purpura (HSP), also called immunoglobulin A vasculitis (IgAV), is a vascular disease that primarily affects small blood vessels. The disease is characterized by abnormal deposits of immunoglobulin A (an antibody) in the blood vessels, leading to their inflammation (vasculitis). The small vessels of the skin, joints, kidneys, and digestive organs are particularly involved. Signs and symptoms usually begin suddenly (and progress over days) and may include purple-colored spots on the skin (purpura); joint pain; and gastrointestinal problems such as abdominal pain, nausea, bloody stools, and rarely, severe complications requiring surgery. People with HSP may also develop glomerulonephritis (injury to the kidneys caused by inflammation) and poor kidney function, which may result in swelling of parts of the body or face (edema), and blood and protein in the urine (hematuria and proteinuria). Most cases of HSP occur in children and go away without causing serious or long-term health problems. Less commonly, the disease affects adults and may be more severe, leading to chronic kidney disease and kidney failure. The cause of HSP is not completely understood, but research indicates that genes (especially those involved in regulating the immune system) may play a key role in predisposing a person to HSP, as well as its severity. However, while genes may increase the risk of developing the disease (and in some cases more than one family member has HSP), the disease itself is not inherited. The diagnosis of HSP may be made based on symptoms, blood and urine tests, imaging studies, and/or a biopsy of the skin or kidney.
What are the alternative names for Henoch-Schonlein Purpura?
  • Henoch-Schonlein purpura
  • Anaphylactoid purpura
  • Henoch Schonlein purpura
  • Immunoglobulin A vasculitis
  • Immunoglobulin-A vasculitis
  • Purpura, Schonlein-Henoch
  • Vascular purpura
Who are the top Henoch-Schonlein Purpura Local Doctors?
Elite in Henoch-Schonlein Purpura
Elite in Henoch-Schonlein Purpura
Rheumatology Div, 
Santander And Univ. Of The Witwatersrand, ZA 

Miguel Gay-Gonzalez practices practicing medicine in Santander And Univ. Of The Witwatersrand, South Africa. Mr. Gay-Gonzalez is rated as an Elite expert by MediFind in the treatment of Henoch-Schonlein Purpura. He is also highly rated in 57 other conditions, according to our data. His clinical expertise encompasses Vasculitis, Temporal Arteritis, Giant Cell Arteritis (GCA), Lung Transplant, and Kidney Transplant.

Elite in Henoch-Schonlein Purpura
Elite in Henoch-Schonlein Purpura
Turin, IT 

Licia Peruzzi practices practicing medicine in Turin, Italy. Ms. Peruzzi is rated as an Elite expert by MediFind in the treatment of Henoch-Schonlein Purpura. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Henoch-Schonlein Purpura, IgA Nephropathy, Glomerulonephritis, Kidney Transplant, and Liver Transplant.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Henoch-Schonlein Purpura
Elite in Henoch-Schonlein Purpura
Turin, IT 

Rosanna Coppo practices practicing medicine in Turin, Italy. Ms. Coppo is rated as an Elite expert by MediFind in the treatment of Henoch-Schonlein Purpura. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses IgA Nephropathy, Glomerulonephritis, Henoch-Schonlein Purpura, Purpura, and Kidney Transplant.

What are the latest Henoch-Schonlein Purpura Clinical Trials?
A Phase 3, Open-Label, Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Ravulizumab in Pediatric Participants (2 to < 18 Years of Age) With Primary Immunoglobulin A Nephropathy (IgAN)

Summary: The primary objectives of this study are to characterize ravulizumab pharmacokinetics (PK) and pharmacodynamics (PD), and to evaluate safety and efficacy following ravulizumab IV dosing in pediatric participants with IgAN or IgAVN.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Randomized Multicenter Study for Isolated Skin Vasculitis

Summary: Multi-center sequential multiple assignment randomized trial comparing the effectiveness of three different standard of care treatment options for patients with isolated skin vasculitis.

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center